Literature DB >> 18576152

Amplification of purified prions in vitro.

Surachai Supattapone1, Nathan R Deleault, Judy R Rees.   

Abstract

The infectious agents of prion diseases are unorthodox, and they seem to be composed primarily of a misfolded glycoprotein called the prion protein (PrP). Replication of prion infectivity is associated with the conversion of PrP from its normal, cellular form (PrP(C)) into a pathogenic form (PrP(Sc)), which is characterized biochemically by relative detergent insolubility and protease resistance. Several techniques have been developed in which PrP(C) molecules can be converted into the PrP(Sc) conformation in vitro. These biochemical techniques recapitulate several specific aspects of in vivo prion propagation, and one method, the protein misfolding cyclic amplification technique, also has been shown to amplify infectivity. In this chapter, we describe a method for amplifying PrP(Sc) molecules from hamster prions in vitro using purified substrates. Specific protocols for substrate preparation, reaction mixture, and product detection are explained. Purified PrP(Sc) amplification assays are currently being used to study the biochemical mechanism of prion formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18576152      PMCID: PMC2700657          DOI: 10.1007/978-1-59745-234-2_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

Authors:  G P Saborio; B Permanne; C Soto
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

2.  Copper (II) ions potently inhibit purified PrPres amplification.

Authors:  Nicholas R Orem; James C Geoghegan; Nathan R Deleault; Richard Kascsak; Surachai Supattapone
Journal:  J Neurochem       Date:  2006-01-17       Impact factor: 5.372

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cell-free formation of protease-resistant prion protein.

Authors:  D A Kocisko; J H Come; S A Priola; B Chesebro; G J Raymond; P T Lansbury; B Caughey
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

5.  Detection of prions in blood.

Authors:  Joaquín Castilla; Paula Saá; Claudio Soto
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

6.  In vitro generation of infectious scrapie prions.

Authors:  Joaquín Castilla; Paula Saá; Claudio Hetz; Claudio Soto
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

7.  Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions.

Authors:  Nathan R Deleault; James C Geoghegan; Koren Nishina; Richard Kascsak; R Anthony Williamson; Surachai Supattapone
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

8.  Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.

Authors:  D A Kocisko; S A Priola; G J Raymond; B Chesebro; P T Lansbury; B Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

9.  Non-genetic propagation of strain-specific properties of scrapie prion protein.

Authors:  R A Bessen; D A Kocisko; G J Raymond; S Nandan; P T Lansbury; B Caughey
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  3 in total

1.  Low density subcellular fractions enhance disease-specific prion protein misfolding.

Authors:  James F Graham; Sonya Agarwal; Dominic Kurian; Louise Kirby; Teresa J T Pinheiro; Andrew C Gill
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

Review 2.  Immunomodulation for prion and prion-related diseases.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

3.  Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones.

Authors:  Joel C Watts; Hairu Huo; Yu Bai; Sepehr Ehsani; Amy Hye Won Jeon; Amy Hye Won; Tujin Shi; Nathalie Daude; Agnes Lau; Rebecca Young; Lei Xu; George A Carlson; David Williams; David Westaway; Gerold Schmitt-Ulms
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.